Arlen Meyers, MD, MBA Healthcare Expert

Arlen Meyers, MD, MBA is a professor emeritus of otolaryngology, dentistry, and engineering at the University of Colorado School of Medicine and the Colorado School of Public Health and President and CEO of the Society of Physician Entrepreneurs at He has created several medical device and digital health companies. His primary research centers around biomedical and health innovation and entrepreneurship and life science technology commercialization. He consults for and speaks to companies, governments, colleges and universities around the world who need his expertise and contacts in the areas of bio entrepreneurship, bioscience, healthcare, healthcare IT, medical tourism -- nationally and internationally, new product development, product design, and financing new ventures. He is a former Harvard-Macy fellow and In 2010, he completed a Fulbright at Kings Business, the commercialization office of technology transfer at Kings College in London. He recently published "Building the Case for Biotechnology." "Optical Detection of Cancer", and " The Life Science Innovation Roadmap". He is also an associate editor of the Journal of Commercial Biotechnology and Technology Transfer and Entrepreneurship and Editor-in-Chief of Medscape. In addition, He is a faculty member at the University of Colorado Denver Graduate School where he teaches Biomedical Entrepreneurship and is an iCorps participant, trainer and industry mentor. He is the Chief Medical Officer at and and Chairman of the Board at GlobalMindED at, a non-profit at risk student success network. He is honored to be named by Modern Healthcare as one of the 50 Most Influential Physician Executives of 2011 and nominated in 2012 and Best Doctors 2013.


How to Improve MedTech

Like all sick care industries, The $379B MedTech indutsry is feeling the impact of the tsumani of sick care change. Veritical integraton is but one trend being driven by the need to come up with system solutions in a risk sharing environment, not just gadgets.


SickWork and Office Space

WeWork now claims the accomplishment of being the number one occupier of office space in Manhattan based on square footage. The Wall Street Journal first reported this news noting the flexible co-working space provider leases 5.3 million square feet of office space. WeWork says with its lease of 258,344 square feet at 21 Penn Plaza  it has topped the 5.2 million square feet of office space that JPMorgan Chase owns or rents. WeWork became the largest private occupier of office space in London and Washington, DC, earlier this year.


Is there a US Doctor Brain Drain?

We read and hear a lot about why doctors are so grumpy. But, are doctors really leaving clinical practice at higher rates compared to the past? Are they just talking, or are they really telling people to take this white coat and shove it? And, what happens when the increasing numbers of employed white coats get the pink slips?


So if Patients are Customers, How do you Sell to Them?

Consumerization of sick care is on everyone's lips. I think patient consumerism, i.e. the belief that if given the right information, patient-consumers will make smart sick care choices based on value, is a myth.


The Sick Care Innovation Scorecard

There is a sick care "innovation" frenzy that is happening both from inside and outside of the industry. The pace of proposed, if not real, change is dizzying and, in many instances, is outpacing the ability of sick care workers and patients to cope with it. But, what is the real impact of all this activity?